Prototype tested by Tim Cook requires no skin penetration.
This week’s news
Lanadelumab could revolutionise treatment of swelling disease.
MindMotion Pro helps with upper-limb rehabilitation following a stroke.
Almost a year after launch, ABPI is confident more doctors will disclose payments
Company aims to hit 5% growth every year
Early warning system should be introduced, says Economist Intelligence Unit.
Drug gets fast review in tough to treat follicular lymphoma
Corporation tax increase could damage UK’s competitiveness, says ABPI
Watson will be used to improve prevention of Substance Use Disorder relapses.
Mary Szela has quit to avoid a conflict of interest.
Trump’s FDA pick also vows to take on opioid addiction crisis
Company still in race to develop CGRP inhibitor for migraine.